Series of essays that identify that pressing public health challenges – such as obesity – will only be addressed through multidisciplinary approaches that build an understanding of individuals in their social and environmental context. But not all disciplines share the same concepts of
This report shares a selection of key findings from the What Works Network, as well as examples of the impact that the centres have had on public services over the past five years. The What Works Network was launched five years ago to embed robust evidence
Improving health outcomes, preventing serious illness, providing convenient, timely and cost effective care, and avoiding the unnecessary use of acute hospitals, is a shared goal across the NHS, and requires a radical re-think about how and where care is delivered,
Report from the Hospital Consultants and Specialists Association that identifies that Sustainability and Transformation Partnerships (STPs) offer potential for organisations across the health and social care systems to work together to develop health policies suited to local needs. However, without adequate funding,
Annual report of the Medicines and Healthcare Products Regulatory Agency’s Review Panel which exists to hear representations, where legislation allows, from those applicants and licence holders who disagree with a decision made by the MHRA. It is able to operate in such way
The evidence suggests that people who have better digital literacy tend to have more positive attitudes and behaviours to adopting new technologies. With the fast pace of change in technologies that are developed to support and improve individual care and outcomes, everyone needs to be
Diabetes pathway defining the core components of an optimal diabetes service for people with or at risk of developing Type 1 and Type 2 diabetes that delivers the better value in terms of outcomes and cost. Its appendix outlines examples of
Evidence-based guidance to support practitioners, commissioners and providers of tier 2 weight management services. It follows the journey of an adult weight management service user in a tier 2 service and provides recommendations, considerations and resources needed to put this in
Report highlighting the significant difficulties patients and some healthcare professionals face in using evidence from research to judge the benefits and harms of medicines, and calls for concerted action to improve the information patients receive. It calls for a range
Annual report from Health Care Libraries Unit North for April 2016 to March 2017 outlining the activities of the Unit for the last financial year.
NHS specialised services, those providing treatment for rare conditions or requiring specialised teams, are commissioned differently in England to most NHS care. Due to the highly specialised nature of services, the relatively small number of hospitals providing some treatments, and the small number
NICE has developed a medtech innovation briefing (MIB) on SecurAcath for securing cerebrospinal fluid catheters.
Evidence-based recommendations on endoscopic full thickness removal of non-lifting colonic polyps. This involves using a special device to remove the polyp and seal the bowel wall closed afterwards.
Evidence-based recommendations on certolizumab pegol (Cimzia) and secukinumab (Cosentyx) for treating active psoriatic arthritis in adults.
NICE has developed a medtech innovation briefing (MIB) on NaviCam for diagnosing gastrointestinal tract conditions.
This literature review aims to show what evidence is available to inform the development of guidance on safe caseloads in district and community nursing adult services.
The focus of this rapid review is to summarise the best available evidence on safe staffing structures of mental health teams to inform the development of specific sustainable safe staffing guidance for the National Safe Sustainable Staffing Guidance Programme Board.
The technology described in this briefing is SimpliCT. It is a laser device used to guide nonvascular puncture procedures in which CT or cone-beam CT imaging is used.
The technology described in this briefing is the TopClosure Tension Relief System (TRS). It is used to stretch skin to improve wound closure after injury or surgical procedures.
Rituximab (MabThera, Roche Products Limited) is a monoclonal antibody. Rituximab is licensed in adults for treating non-Hodgkin’s lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, and granulomatosis with polyangiitis and microscopic polyangiitis. It is administered as an intravenous infusion. Rituximab is not